FLARAXIN Tablets are antiviral, anti-inflammatory, anti-cancer, immuno-modulatory, stimulate the production of interferon, prevent bacterial and viral damage of ENT organs, as well as acute respiratory viral infections, influenza, SARS, etc. viral infections, cerebrovascular hypertension, arachnoiditis, viral encephalitis, dyscirculatory encephalopathy, migraine, transient ischemic brain attacks, cardiovascular diseases, cancer in the oral cavity and brain and benign neoplasms (cyst formation).
FLARAXIN Tablets - can be widely used for prophylactics and treatment of inflectional, somatic, viral and oncologic diseases. They are a preparation of organic origin. The acting components are organic polyphenols, obtained through our vacuum-condensation technology.
FLARAXIN Tablets are an effective natural inducer of interferon and stimulate antitumor, antiviral, immunomodulating action. They stimulate the natural bodily synthesis of interferons such as alpha and gamma with a duration of up to 72 hours while also stimulating the growth of stem cells. They can effectively be used used for bacterial and viral injuries of ENT organs, in the treatment and prevention of ARVI, influenza and other viral infections, with the transferred craniocerebral injuries, cerebrovascular hypertension, arachnoiditis, viral encephalitis, cerebral circulatory disorders, dyscirculatory encephalopathy, migraine, transient ischemic attacks of the brain, and cardiovascular diseases. They have a pronounced antispasmodic effect on the blood vessels of the brain and the heart. It relieves headaches and migraines. In oncological processes in the oral cavity and brain, benign neoplasms (cyst formation).
FLARAXIN Tablets can be appointed to adults, being effective in:
Disorders of the cerebral blood circulation, treatment of stroke therapy and pre-stroke states and conditions;
Preventing bacterial and viral damage of ENT organs, acute respiratory viral infection (respiratory chlamydia, herpes), influenza, ARVI, SARS, etc. ;
Viral infections, cerebrovascular hypertension, arachnoiditis, viral encephalitis, dyscirculatory encephalopathy, migraines, transient ischemic brain attacks, cardiovascular diseases, oral and brain cancer, benign neoplasms (cyst formation including ovarian cysts), etc.;
Treatment of tuberculosis;
For children older than 7 years, FLARAXIN Tablets may be prescribed for the treatment of acute respiratory viral infections and influenza.
FLARAXIN is an effective natural inducer of α and γ interferon. It stimulates the synthesis of type alpha and gamma interferon in the body. The highest production of interferon in the blood is detected 6-8 hours after intake, and the higher production levels of interferon titer continue for 72 hours after intake.
FLARAXIN stimulates the growth of stem cells, and is best characterised by its mild immunomodulatory effects and its direct antiviral action. It efficiently destroys infections by destroying viruses and bacteria at the cause, while also improving the capillary blood flow.
One tablet contains 150mg Tannin, 120mg Kelp extract, 65mg Sugar, 29mg Lactose, 116mg Starch, 10mg Microcel® MC-101, 5mg Magnesium Stearate, 5mg Aerosil, Vitamins C, E, PP.
FLARAXIN Tablets should not be used during pregnancy. If there is an acute need for the use of FLARAXIN Tablets during lactation, breastfeeding should be discontinued.
Interaction with other medicine
To date, there has been no clinically significant interaction of FLARAXIN Tablets with any other methods of treatment of bacterial and viral infections or with antibiotics.
At the moment, there are no known cases of overdose of this remedy.
Flaraxin is contraindicated in pregnant women, children under 7 years of age and those who are hypersensitive to the remedy.
Must be stored in a dry, dark and unreachable to children place at a temperature between 20° C to 25° C and humidity levels under 70%.
Form of Issue
Biconvex tablets of 150mg, 20 pcs. in one plastic container.